EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Synthesis of Pyridyl and 2-Hydroxyphenyl Chalcones with Antitubercular Activity

Kelphina Aziafor, Ketan Ruparelia, Brandon Moulds, Mire Zloh iD, Tanya Parish, Federico Brucoli iD

Molecules · 2024

DOI: 10.3390/molecules29194539 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Kelphina Aziafor und 5 weiteren Autor:innen. Beteiligte Einrichtung: Leicester School of Pharmacy, De Montfort University, Leicester LE1 9BH, UK. Hauptthemen laut MEDLINE: Chalcones, Antitubercular Agents, Mycobacterium tuberculosis, Molecular Docking Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Seattle Tuberculosis Research Advancement Center (SEA-TRAC) at the University of Washington/Seattle Children’s Research Institute/red Hutch Center for AIDS Res….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A focussed library of pyridyl and 2-hydroxyphenyl chalcones were synthesized and tested for growth inhibitory activity against Mycobacterium tuberculosis H37Rv, and normal and cancer breast cell lines. Pyridyl chalcones bearing lipophilic A-ring, e.g., dichloro-phenyl-(14), pyrene-1-yl (20)- and biphenyl-4-yl (21) moieties were found to be the most potent of the series inhibiting the growth of M. tuberculosis H37Rv with IC90 values ranging from 8.9–28 µM. Aryl chalcones containing a 3-methoxyphenyl A-ring and either p-Br-phenyl (25) or p-Cl-phenyl (26) B-rings showed an IC90 value of 28 µM. Aryl-chalcones were generally less toxic to HepG2 cells compared to pyridyl-chalcones. Dose-dependent antiproliferative activity against MDA468 cells was observed for trimethoxy-phenyl (16) and anthracene-9-yl (19) pyridyl-chalcones with IC50 values of 0.7 and 0.3 µM, respectively. Docking studies revealed that chalone 20 was predicted to bind to the M. tuberculosis protein tyrosine phosphatases B (PtpB) with higher affinity compared to a previously reported PtpB inhibitor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChalconesAntitubercular AgentsMycobacterium tuberculosisMolecular Docking SimulationHumansDrug DesignCell Line, TumorStructure-Activity RelationshipHep G2 CellsMicrobial Sensitivity TestsCell ProliferationMolecular Structure

Stichwörter der Autor:innen

breast cancerchalconesclaisen condensationmycobacterium tuberculosisprotein tyrosine phosphatase B (Mbt PtpB)

Substanzen

ChalconesAntitubercular Agents

Autor:innen und Institutionen

  • Leicester School of Pharmacy, De Montfort University, Leicester LE1 9BH, UK.
  • Faculty of Pharmacy, University Business Academy, 21000 Novi Sad, Serbia.
  • UCL School of Pharmacy, University College London, 29/39 Brunswick Square, London WC1N 1AX, UK.
  • Center for Global Infectious Disease Research, Seattle Children's Research Institute, 307 Westlake Avenue North, Suite 500, Seattle, WA 98102, USA.

ORCID-Profile: Mire Zloh, Federico Brucoli

Förderung

  • NIAID NIH HHS
  • Seattle Tuberculosis Research Advancement Center (SEA-TRAC) at the University of Washington/Seattle Children’s Research Institute/red Hutch Center for AIDS Res…

Zitieren

APA

Aziafor, K., Ruparelia, K., Moulds, B., Zloh, M., Parish, T., & Brucoli, F. (2024). Design and Synthesis of Pyridyl and 2-Hydroxyphenyl Chalcones with Antitubercular Activity. Molecules. https://doi.org/10.3390/molecules29194539

Vancouver

Aziafor K, Ruparelia K, Moulds B, Zloh M, Parish T, Brucoli F. Design and Synthesis of Pyridyl and 2-Hydroxyphenyl Chalcones with Antitubercular Activity. Molecules. 2024. doi:10.3390/molecules29194539

BibTeX
@article{Aziafor2024,
  author = {Aziafor, Kelphina and Ruparelia, Ketan and Moulds, Brandon and Zloh, Mire and Parish, Tanya and Brucoli, Federico},
  title = {Design and Synthesis of Pyridyl and 2-Hydroxyphenyl Chalcones with Antitubercular Activity},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29194539}
}
Kostenlos starten →